Revenue
Revenue Recognized from Contract Liabilities
West Pharmaceutical Services Revenue Recognized from Contract Liabilities increased by 126.5% to $23.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.2%, from $18.30M to $23.10M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Consistent recognition of deferred revenue indicates a healthy pipeline of service delivery and stable business operations.
Detailed definition
This metric tracks the portion of revenue recognized during the period that was previously recorded as deferred revenue...
Peer comparison
Commonly analyzed for SaaS and subscription-based business models.
Metric ID:
isrg_contract_liability_revenue_recognizedHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.00M | $1.60M | $9.70M | $7.80M | $6.10M | $21.30M | $6.10M | $5.80M | $15.50M | $8.70M | $8.60M | $18.30M | $10.80M | $10.20M | $23.10M |
| QoQ Change | — | -85.5% | +506.3% | -19.6% | -21.8% | +249.2% | -71.4% | -4.9% | +167.2% | -43.9% | -1.1% | +112.8% | -41.0% | -5.6% | +126.5% |
| YoY Change | — | — | — | -29.1% | +281.3% | +119.6% | -21.8% | -4.9% | -27.2% | +42.6% | +48.3% | +18.1% | +24.1% | +18.6% | +26.2% |
Range$1.60M – $23.10M
CAGR+23.6%
Avg YoY Growth+41.3%
Median YoY Growth+21.4%
Revenue Recognized from Contract Liabilities at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's revenue recognized from contract liabilities?
- West Pharmaceutical Services (WST) reported revenue recognized from contract liabilities of $23.10M in Q1 2026.
- How has West Pharmaceutical Services's revenue recognized from contract liabilities changed year-over-year?
- West Pharmaceutical Services's revenue recognized from contract liabilities increased by 26.2% year-over-year, from $18.30M to $23.10M.
- What does revenue recognized from contract liabilities mean?
- Revenue recognized this period that was previously held as deferred revenue.